OPENING CEREMONY
HONORARY MEMBER AWARDS
Judith Marsh (United Kingdom)
Fred Falkenburg (Netherlands)
Noel Milpied (France)
CLINICAL ACHIEVEMENT AWARD
Richard Burt (United States)
Watch the EBMT TV interview
PRESIDENTIAL SYMPOSIUM
VAN BEKKUM AWARD to Jeremy Abramson (United States) for his abstract entitled: GS2-02 LISOCABTAGENE MARALEUCEL VERSUS STANDARD OF CARE (SALVAGE CHEMOTHERAPY FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION) AS SECOND-LINE THERAPY IN RELAPSED/REFRACTORY LBCL: TRANSFORM RESULTS
Watch the EBMT TV interview
BASIC SCIENCE AWARD to Sascha Göttert (Germany) for his abstract entitled: GS2-04 MICROBIAL-DERIVED METABOLITES INDUCE EPITHELIAL RECOVERY VIA THE STING PATHWAY IN MICE AND MEN AND PROTECT FROM GRAFT-VERSUS-HOST DISEASE
Watch the EBMT TV interview
ABSTRACT AWARDS
JIAN-JIAN LUAN AWARD to Ron Ram (Israel) for his abstract entitled: DAY+7 ANTI CD19-CAR-T BLOOD CONCENTRATIONS IDENTIFY ULTRA-HIGH-RISK GROUP FOR EARLY PROGRESSION OF DISEASE IN PATIENTS WITH STABLE/PROGRESSIVE DLBCL AT LYMPHODEPLETION
Watch the EBMT TV interview.
JON J. VAN ROOD AWARD to Kristina Maas-Bauer (Germany) for her paper entitled: INVARIANT NATURAL KILLER T-CELL SUBSETS HAVE DIVERSE GRAFT-VERSUS-HOST-DISEASE–PREVENTING AND ANTITUMOR EFFECTS
Watch the EBMT TV interview
CLOSING SESSION
BEST YOUNG ABSTRACTS
10 BEST YOUNG ABSTRACT AWARDS
- Mizuki Watanabe (Japan) - OS01-01 CORD BLOOD TRANSPLANTATION FOR ADULT LYMPHOID NEOPLASMS IN EUROPE AND JAPAN: A COLLABORATIVE STUDY BETWEEN EUROCORD/LWP-EBMT AND JSTCT/JDCHCT
- Amanda I Perez-Valencia (Spain) - OS05-01 INCREASED EARLY CARDIAC TOXICITY IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION COMBINED WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
- Carmelo Gurnari (United States) - OS11-01 DETERMINANTS OF CLONAL EVOLUTION IN APLASTIC ANEMIA
- Sjoerd J. F. Hermans (Netherlands) - OS12-01 PREDICTION OF NON-RELAPSE MORTALITY IN PATIENTS WITH AML AND ALL RECEIVING ALLOSCT IN FIRST CR WITH POST-TRANSPLANTATION CYCLOPHOSPHAMIDE-BASED GVHD PROPHYLAXIS
- Olga Molostova (Russian Federation) - OS13-01 CD19 CAR-T THERAPY IN CHILDREN WITH RELAPSED AND REFRACTORY B-CELL ALL
- Linqin Wang (China) - OS13-02 PROFILES OF CYTOKINES ARE ASSOCIATED WITH PROLONGED HEMATOLOGIC TOXICITIES AFTER BCMA TARGETED CAR-T CELL THERAPY
- Nicolas Gazeau (United States) - OS13-03 IMPACT OF ANAKINRA DOSE ON OUTCOMES IN PATIENTS WITH REFRACTORY CRS AND/OR ICANS AFTER CAR T-CELL THERAPY
- Claire Horgan (United Kingdom) - OS18-01 EXCELLENT OUTCOMES AFTER T-REPLETE UNRELATED DONOR CORD BLOOD TRANSPLANT TO CURE HIGH RISK AND REFRACTORY PAEDIATRIC AML AND MDS
- Lisa V.E. Oostenbrink (Netherlands) - OS18-03 EXPOSURE-RESPONSE ANALYSIS OF ATLG GRAFALON® IN PAEDIATRIC ALL PATIENTS: TOWARDS INDIVIDUALIZED DOSING TO PREVENT ACUTE GVHD AFTER HSCT
- Maria Queralt Salas (Canada) - OS19-01 HCT FRAILTY SCALE FOR ADULTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
5 BEST YOUNG POSTER AWARDS
- Hao Yao (Germany) - P079 ENHANCEMENT OF LONG-TERM FUNCTIONALITY OF CD19 CAR-T CELLS BY OVEREXPRESSION OF TCF-1
- Patrick Derigs (Germany) - P088 3RD-GENERATION CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELLS (CARTS) FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) – RESULTS FROM AN ACADEMIC PHASE 1/2 TRIAL (HD-CAR-1)
- Francesca Biavasco (Germany) - P202 REAL-WORLD DATA ON RUXOLITINIB IN STEROID-REFRACTORY ACUTE INTESTINAL GRAFT-VERSUS-HOST-DISEASE
- Jean-Sebastien Claveau (United States) - P203 BORTEZOMIB MAINTENANCE AFTER UPFRONT ALLOGENEIC TRANSPLANTATION IN MYELOMA PATIENTS: LESS CHRONIC GVHD AND IMMUNOSUPPRESSION BUT STILL NO IMPACT ON SURVIVAL
- Gianluca Dell'Orso (Italy) - P472 HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR INHERITED IMMUNE DISORDERS : 30-YEAR ITALIAN SINGLE- CENTER EXPERIENCE
SPRINGER NATURE POSTER AWARDS
The Best Clinical Poster Award, sponsored by Springer, was presented to Zaid Al-Kadhimi (United States) - P449 RE-FOCUSING ATG TOWARDS HOST T-CELL DEPLETION ELIMINATES GRADE III-IV ACUTE GVHD AND IS ASSOCIATED WITH EARLY GRAFT VERSUS LEUKEMIA (GVL) IMMUNE RESPONSES
The Best Science Poster Award, sponsored by Springer, was presented to Hao Yao (Germany) - P079 ENHANCEMENT OF LONG-TERM FUNCTIONALITY OF CD19 CAR-T CELLS BY OVEREXPRESSION OF TCF-1
PHARMACISTS AWARDS
BEST PHARMACISTS ABSTRACTS
Midori Nakagaki (Australia) - Pharm3-01 WEIGHT-BASED DOSING OF CICLOSPORIN A IN OBESE PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: SERUM LEVELS AND CLINICAL OUTCOMES
Adrin Dadkhah (Germany) - Pharm3-02 POPULATION PHARMACOKINETICS OF BUSULFAN AND ITS METABOLITE SULFOLANE IN PATIENTS WITH MYELOFIBROSIS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Liana Klejmont (United States) - Pharm3-03 THE SAFETY, FEASIBILITY, AND EFFICACY OF GANCICLOVIR PROPHYLAXIS THROUGH DAY +100 IN PEDIATRIC ALLOSCT RECIPIENTS: BONE MARROW SUPPRESSION SECONDARY TO GANCICLOVIR MAY LIMIT EFFECTIVENESS
Watch the EBMT TV interview
EBMT NURSES GROUP AWARDS
14th DISTINGUISHED MERIT AWARD to Iris Agreiter
HONORARY MEMBERS 2022 to John Murray and Helen Jessop
BEST RESEARCH ABSTRACT ORAL PRESENTATION to Arianna Rosich-Soteras (Spain) - NG09-02 INFORMAL CAREGIVER OF THE HSCT RECIPIENT: PROFILE, MENTAL HEALTH AND QUALITY OF LIFE IMPACT. PRELIMINARY RESULTS IN A THIRD-LEVEL SPANISH HOSPITAL
BEST ORAL PRESENTATION (ADULT) to Jeanette Winterling (Netherlands) for her abstract entitled: NG07-03 PERSON-CENTRED SUPPORT FOR FAMILY CAREGIVERS IN THE CONTEXT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION – FEASIBILITY OF A REMOTELY DELIVERED INTERVENTION
BEST ORAL PRESENTATION (PAEDIATRIC) to Kim van der Niet (Netherlands) - NG07-04 SKIN CARE IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS RECEIVING THIOTEPA AND TREOSULFAN.
BEST POSTER PRESENTATION (ADULT) to Cassandra Ixena Andersson-Vila (Spain) - NP014 QUALITY OF LIFE PATTERN IN PATIENTS WITH MULTIPLE MYELOMA INFUSED WITH CAR-T THERAPY
BEST POSTER PRESENTATION (PAEDIATRIC) to James Evans (United Kingdom) - NP039 GASTROSTOMY FEEDING IS SAFE AND EFFECTIVE IN IMPROVING THE NUTRITIONAL STATUS OF CHILDREN WITH CANCER AND THOSE UNDERGOING BONE MARROW TRANSPLANT: A SYSTEMATIC REVIEW